Using Whole Blood for Trauma Patients in Canada
Official title: SWiFT Canada (Study of Whole Blood in Frontline Trauma): A Pilot Randomized Controlled Trial Assessing Prehospital Whole Blood Versus Component Therapy in Traumatic Hemorrhage
Run by Unity Health Toronto · NCT06495294 · Data updated 2026-11-12
This study tests if giving whole blood right away to trauma patients in Canada helps them survive better than the usual blood transfusions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Unity Health Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | December 16, 2024 |
| Main results expected | December 2026 |
| Study ends | March 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT06495294 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults who have suffered a traumatic injury and require prehospital blood transfusion.
✕Probably not a fit
Patients under 16 years old or those who have already received blood transfusions on-scene will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of prehospital whole blood transfusion compared to traditional component therapy in patients with major traumatic hemorrhage. Conducted in collaboration with the SWiFT UK team, it aims to establish a protocol for administering whole blood in emergency settings, potentially improving survival rates. The trial will involve patients who have suffered traumatic injuries and require immediate blood transfusion by participating clinical teams. The study is designed to gather high-quality clinical evidence to support the use of whole blood in prehospital care across Canada.
Why it matters
Potential benefit: If successful, this study could significantly improve survival rates for trauma patients experiencing major hemorrhage.
How similar studies have gone: While there is some evidence supporting the use of whole blood, this study is among the first to rigorously evaluate its effectiveness in the Canadian prehospital setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient who has suffered a traumatic injury * Attended by a participating Ornge AAS clinical team * Requires prehospital blood transfusion to treat major traumatic hemorrhage Exclusion Criteria: * Pediatric (age \<16 or transported to pediatric trauma centre \[if age unknown\]) * No intravenous or intraosseous access (should be assessed prior to opening box) * Knowledge that patient will object to being given blood transfusion for any reasons * Blood already administered on-scene, prior to arrival of the participating Ornge AAS
Where it's running
-
Ornge Air Ambulance
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Brodie Nolan, MD MSc — Unity Health Toronto
- Study coordinator: SWiFT Canada
- Email: swift@unityhealth.to
- Phone: 437 778 2260
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
Supporting social and economic equity to help young people move out of homelessness and thrive
This pilot will try an 18-month wraparound program of job help, housing supports, grocery supplements, coaching and community connection for 18–24-year-olds who recently experienced homelessness to see if they engage and find it helpful.
-
Digital app to support oncologist‑initiated genetic testing
This project tests a digital app (GA‑Mainstream) to help oncologists offer germline genetic testing to adults with breast, prostate, colon, or other GI cancers.
-
TreatResp: adaptive study of breathing infections therapies for community care
This trial tests baloxavir vs. standard care in adults with influenza or similar respiratory infections to see if new treatments help people recover faster when kept at home.
-
MDMA for severe chronic neuropathic pain
This will try a single oral dose of MDMA combined with psychotherapy to see if it reduces pain and improves function in adults with moderate-to-severe chronic neuropathic pain that hasn't responded to standard medications.
-
AbClo abdominal binder's effects on breathing mechanics in ventilated patients with an open abdomen
This test will see if adjusting the AbClo abdominal binder changes lung pressures, lung volume, and breathing function in adults on ventilators with an open abdomen.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.